Doug Harrington, MD Reveals "Why Heart Attacks Happen to 'Healthy People'" at Educational Cardiovascular Symposiums
IRVINE, Calif., Nov. 5, 2013 /PRNewswire/ -- Dr. Doug Harrington, clinical professor at USC Keck School of Medicine, presented "Why Do Heart Attacks Happen to 'Healthy People'?" on behalf of nonprofit, GUARDaHEART at both the 13th Annual Maui Cardiovascular Symposium and at the 5th Annual Orange County Symposium.
(Logo: http://photos.prnewswire.com/prnh/20130319/LA79677LOGO)
(Logo: http://photos.prnewswire.com/prnh/20130821/LA67312LOGO)
Dr. Harrington's presentations addressed the issue of why half of patients who have heart attacks have normal cholesterol. Harrington revealed the latest data on Aviir's MIRISK VP® advanced cardiovascular risk assessment test, which can improve identification of at risk patients by determining their risk for the #1 cause of heart attacks – vulnerable plaque rupture. MIRISK VP evaluates multiple pathways of heart disease progression and can help physicians diagnose "vulnerable patients" who may be unaware of their risk of a heart attack or unstable angina.
The November Orange County Symposium entitled "A Brave New World: Navigating Through Problems in Contemporary Cardiovascular Disease Prevention and Management" was jointly sponsored by the American Society for Preventive Cardiology and AKH Inc. The Pacific Lipid Association, the California Chapter of the ACC, and the California Chapter of AACE endorsed the conference. Hosting committee member, Nathan D. Wong, PhD, F.A.C.C. commented "the work of GUARDaHEART in helping people to better understand their cardiovascular health using novel risk assessment tools is a commendable mission and an important step towards helping America and other parts of the world reduce cardiovascular disease."
The October Maui Cardiovascular Symposium was presented by John B. Gordon III, M.D., F.A.C.C., and was jointly organized by the San Diego Medical Program and the San Diego Cardiac Center. The event was endorsed by the Hawaii and California Chapters of the ACC.
About GUARDaHEART
GUARDaHEART is a non-profit foundation dedicated to raising awareness and powering prevention of heart disease by spreading the word to "guard your heart and save your life". Cardiovascular disease is the leading cause of death in the United States. GUARDaHEART is dedicated to promoting the fact that if individuals know their risk and take the necessary steps to lower the risk of heart disease, most cardiovascular disease is preventable. GUARDaHEART provides financial assistance for individuals who are unable to pay for cardiac risk assessments and supports programs and additional resources to lower the risk of heart disease. Please visit www.guardaheart.org and/or www.savethe1.org for more information.
About Aviir®
Aviir was founded in 2005 by a group of cardiologists and scientists from the Stanford University School of Medicine. Aviir is focused on the discovery, development, and commercialization of innovative diagnostic tests, with an emphasis on identifying patients at-risk of a cardiac event. Aviir's proprietary MIRISK® and MIRISK VP® cardiac tests have demonstrated significant improvement in the identification of individuals at risk of a heart attack. Aviir's CLIA-certified laboratory in Irvine, CA also offers a wide range of standard of care testing in addition to testing for cardiovascular assessment and therapeutic monitoring of cardiovascular disease and related metabolic disorders – including advanced pharmacogenomic and genetic tests. The company has adopted a unique clinical laboratory service model to provide physicians better diagnostic tools to help improve the cardiovascular health of their patients. The company is privately owned and funded by leading life science venture capital firms.
Contacts
GUARDaHEART
Vivie Sumadi
[email protected]
(949) 398-6300 x 6355
Aviir
Brittany Rothnem
[email protected]
(949) 398-6300 x 6373
SOURCE Aviir; GUARDaHEART
Share this article